A. Modesto

51 papers receiving 655 citations

A. Modesto's Hit Papers

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse. 2025 · 28 citations
280+1+2Years since publication4080120

Peers

A. Modesto
Comparison fields: 5 of 48
  • Otorhinolaryngology 218
  • Oncology 177
  • Radiation 34
  • Pulmonary and Respiratory Medicine 77
  • Genetics 18
Replace Thomas Jouffroy with:
Thomas Jouffroy France
Derui Li China
Ariel E. Birnbaum United States
Yuanhu Yao China
Monique Luboinski France
Yong Hu China
Sai‐Lan Liu China
Shan-Shan Guo China
Shuichi Kanamori Japan
Forn‐Chia Lin Taiwan
A. Modesto relative to Thomas Jouffroy France Thomas Jouffroy's profile →
Citations per field
00.5×2×4×6×
Thomas Jouffroy · 1×
Citations per year

Countries citing papers authored by A. Modesto

Since Specialization
Citations

This map shows the geographic impact of A. Modesto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Modesto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Modesto more than expected).

Fields of papers citing papers by A. Modesto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Modesto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Modesto. The network helps show where A. Modesto may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Modesto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Modesto Line = papers co-authored together A. Modesto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Hit paper breakdown →
2022135
2 201786
3 201342
4 201837
5
NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.
Hit paper breakdown →
202528
6 202025
7 201722
8 202121
9 202220
10 202017
11 201216
12 201415
13 201715
14 202014
15 202014
16 201312
17 202012
18 201911
19 202111
20 201310

About A. Modesto

A. Modesto is a scholar working on Otorhinolaryngology, Radiation, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 54 papers that have together received 665 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (19 papers), Advanced Radiotherapy Techniques (6 papers), Esophageal Cancer Research and Treatment (5 papers), Brain Metastases and Treatment (4 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Otorhinolaryngology (218 citations), Oncology (177 citations), Radiation (34 citations), Pulmonary and Respiratory Medicine (77 citations) and Genetics (18 citations). A. Modesto has collaborated with scholars based in France, Switzerland and Spain. Frequent co-authors include Jean‐Pierre Delord, Elizabeth Cohen‐Jonathan Moyal, Vincent Sibaud, Carlos Gomez‐Roca, Ciprian Chira, Nicolás Meyer, Serge Boulinguez, Léonor Chaltiel, Martine Delannes and Yungan Tao. Their work appears in journals such as Strahlentherapie und Onkologie, European Journal of Surgical Oncology, Melanoma Research, Oral Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact